Veno-occlusive Disease
📧 Sign up to get email alerts when something new happens for Veno-occlusive Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Defibrotide Dose-escalation for SOS Post-HSCT [Phase 2]
A phase 2 clinical trial is evaluating dose escalation of defibrotide for Sinusoidal Obstruction Syndrome/Veno-occlusive Disease after hemat…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Ultrasound Elastography to Predict Development of SOS [NA]
Clinical trial using ultrasound elastography to predict sinusoidal obstruction syndrome in transplant patients has been terminated. Results …
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients [Phase 3]
Phase 3 trial comparing defibrotide to best supportive care for prevention of hepatic veno-occlusive disease in adults and children has comp…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: 5-day Defibrotide Treatment for Hepatic SOS/VOD [Phase 2]
Phase 2 trial evaluating 5-day defibrotide treatment for Sinusoidal Obstruction Syndrome/Veno-occlusive Disease (related to bone marrow tran…
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT [Phase 2, Phase 3]
Phase 2/Phase 3 pharmacokinetic study assessing Lipo-PGE1 for prevention of veno-occlusive disease after hematopoietic stem cell transplanta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating defibrotide for liver damage due to veno-occlusive disease after peripheral stem cell transplantation; the study ha…